Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III-IV, Multicenter Open Label Trial of Arimidex Alone Versus Arimidex Plus Bisphosphonates in Postmenopausal Patients With Early, Endocrine Positive Breast Cancer.

NCT00809484 is registered in ClinicalTrials.gov with Hellenic Breast Surgeons Society as lead sponsor.

NCT NCT00809484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00809484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III-IV, Multicenter Open Label Trial of Arimidex Alone Versus Arimidex Plus Bisphosphonates in Postmenopausal Patients With Early, Endocrine Positive Breast Cancer.
Lead sponsor
Hellenic Breast Surgeons Society
Phase
Observational
Overall status
Completed
Start date
May 31, 2004
Completion date
February 28, 2007
Enrollment
220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone density, breast cancer